3 Worst Monthly Performers: FXCM Inc (FXCM), Cache Inc (CACH), And KaloBios Pharmaceuticals Inc (KBIO)

Posted by Lynn Eisler January 28, 2015 0 Comment 870 views

New York, NY – GDP INSIDER  – 01/28/2015.

FXCM Inc (NYSE:FXCM) has seen its shares declining nearly 86% over the past one month. The foreign exchange brokerage continued its decline in yesterday’s session, losing 2.46% to end the day at $2.38. The stock traded in the range of $2.26 to $2.47, around 11.65 million shares exchanged hands, against the average daily volume of 16.68 million shares. At the end of the session,  FXCM was up 2.59% from the opening price of the day, but remained 86.54% below its 52-week high.

FXCM Inc (NYSE:FXCM) has been under pressure, since it disclosed that its clients made huge losses when the Swiss National Bank removed the country’s currency cap against the euro. FXCM suffered $225 million capital loss, forcing it to secure $300 million in term loan to boost its capital base.

Is FXCM Inc Going To Continue Selling Off Or Will Things Start Turning Around Soon? See What’s Next For FXCM With A Free Trend Report

Cache Inc (NASDAQ:CACH)’s shares have declined almost 83% in the past one month. At the end of yesterday’s session, shares of the specialty retailer stood 99.22% below its 52-week high, losing 2.29% to close the day at $0.0426. The stock traded in the range of $0.04 and $0.05, on a day that saw a volume of 1.15 million shares, against the average daily volume of 1.2 million.

Cache Inc (NASDAQ:CACH) saw its sales down 2.3% sequentially in the most recent quarter. There have been speculations that the apparel retailer may file for bankruptcy such it struggles to make sales amid cash shortage.

Could Cache Inc Continue To Fall Or Will We Find Support In The Near Future? See What Is In The Cards For CACH With A Complementary Trend Analysis.

KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)’s shares stand down more than 73% over the past four weeks. However, yesterday’s session ended positively for the company as shares edged up 4.61% to end the session at $0.42. The stock was traded in the range of $0.38-$0.43, having opened at $0.40. Yesterday’s gain put the shares of KBIO 5% above the 52-week low price but remained 92.06% below the 52-week high.

KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) is owned 18.94% by insiders. The company grew its EPS 48.9% in the most recent quarter compared with the previous one.

Could KaloBios Pharmaceuticals Inc Reverse From Here Or Will Momentum Continue? Get A Hint As To What’s Coming Next With A Free Trend Analysis Report

About HotStockGains

HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.

Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.

About Lynn Eisler

Lynn Eisler is a national news reporter focusing on economic issues, data analysis and the financial health of state and local governments. Lynn has been honored with the H.L. Mencken Award for Investigative Reporting, the Champion of Justice Award for reporting on the drug war, and the John Hancock Award for business reporting. Lynn was also a Knight Medical School Fellow at the University of Michigan.

View all post by Lynn Eisler Visit author's website

Write Your Comment